The use of AI & ML to improve clinical trials is currently a hot topic. But, do we have a common vernacular around AI, ML, and automation – and an understanding of their differences?
Watch Director of Oncology Data Management at GSK, Magda Jaskowska, and Senior Director, CDB Strategy at Veeva, Edward Jones, share their thoughts and answer questions during a comprehensive discussion. Together they cover how to avoid the hype of AI and the vital role automation plays in creating quality data for a stronger AI strategy.
Watch this on-demand to learn:
- The definitions, risks, and benefits of AI, ML, and automation
- Fit-for-purpose use cases
- How to separate hype from value
Read this blog post to further explore AI & ML, and identify practical and focused use cases that improve clinical study execution.